Back to School: How biopharma can reboot drug development. Access exclusive analysis here

IMC-1121B: Phase II started

IMCL began an open-label Phase II trial to

Read the full 85 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE